The effect of quercetin in prediabetes patients
Phase 3
- Conditions
- Prediabetes.Abnormal glucoseR73.0
- Registration Number
- IRCT20210531051459N3
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
People with prediabetes with fasting blood sugar (greater than or equal to 100 and less than 125 mg/dL) or increased blood sugar two hours after prescribing glucose (greater than or equal to 140 and less than 200 mg/dL) or hemoglobin A1C range 5.7% to 6.4%
Aged 18 years and older
Conscious consent to participate in the study
Exclusion Criteria
Pregnancy and lactation
consumption of hypoglycemic drugs
Consumption of quercetin in the last three months
Taking of crocin and curcumin supplementations
History of liver and kidney failures and cardiovascular diseases
Cancer and autoimmune diseases
Dissatisfaction with participating in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method